Year: 2026
Type: review
Abstract: Purpose of the Review: , along with rarer causes. Available test methods, surveillance activities, current challenges and limitations are included as well as a discussion on testing for bacterial meningitis that is performed clinically and at public health laboratories. Recent Findings: Although clinical laboratories can provide rapid Gram staining and FDA approved PCR testing to detect bacterial meningitis pathogens, culture can be unsuccessful with the initiation of antibiotic therapy at the onset of meningitis symptoms. Public Health laboratories can provide additional molecular testing on primary specimens using laboratory developed tests (LDTs) to detect these pathogens, determine a molecular serotype, and assess antimicrobial resistance. When isolates are available, antimicrobial susceptibility testing, serogroup/serotype determination, and whole genome sequencing can be utilized for support surveillance and outbreak investigations, improve vaccine development, and ultimately reduce the burden of disease. Summary: This review discusses causes of bacterial meningitis and the role that public health laboratories can play in clinical, surveillance and investigation testing to further characterize isolates or specimens, determine if transmission has occurred in investigations, and continue to provide comprehensive data to inform and improve vaccines.
Authors: Kara Mitchell, Kimberlee A. Musser
Institutions: New York State Department of Health, Wadsworth Center
Language: English
Subfield: Microbiology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: bacterial meningitis, public health laboratories, molecular diagnosis, laboratory-developed tests, serotyping, antimicrobial resistance, antimicrobial susceptibility testing, whole genome sequencing, outbreak investigation, disease surveillance, vaccine development, PCR testing, Gram staining
Open Access status: hybrid
Estimated APC paid: $4,790
OpenAlex ID: W7233956436
